Belgium launches investigation of AstraZeneca vaccine plant
EU wants to know whether doses produced on its territory have been diverted to UK
Belgian regulators have launched an investigation into AstraZeneca’s coronavirus vaccine production site near Brussels on the request of the European commission, in an escalation of the row over shortages within the EU.
A first visit by officials from the Belgian federal medicines agency was completed on Wednesday at the site in Seneffe, in Hainaut, the health ministry in Belgium said. Samples and records were taken from the plant and a further inspection of the facility is expected in the coming days.